Skip to content

13F-HR filed by Foresite Capital Management IV, LLC

Foresite Capital Management IV, LLC filed this 13F-HR for the quarter ended 2019-03-31, filed 2019-05-14, with 16 holding rows worth $278,257,000.

Accession
0001144204-19-025824
Filed
2019-05-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2019

A holdings report, 16 entries on the cover page, a total value of $278,257,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $278,257,000 with VALUE read as thousands by filing date, 13F file number 028-18415. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
INSMED INC COM PAR $.01457669307Stock1,533,883$44,590,000thousands by filing date
CYMABAY THERAPEUTICS INC23257D103COM2,631,258$34,943,000thousands by filing date
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR245,424$28,886,000thousands by filing date
BIOHAVEN PHARMACEUTICAL HOLDING11196105COM518,560$26,690,000thousands by filing date
OPTINOSE INC68404V100COM2,427,403$25,002,000thousands by filing date
IMMUNOMEDICS INC452907108COM1,161,965$22,321,000thousands by filing date
MYOKARDIA INC62857M105COM384,993$20,016,000thousands by filing date
REPLIMUNE GROUP INC76029N106COMMON STOCK1,229,656$18,715,000thousands by filing date
CYTOKINETICS INC23282W605COM NEW1,723,170$13,940,000thousands by filing date
RHYTHM PHARMACEUTICALS INC76243J105COM405,026$11,102,000thousands by filing date
ALECTOR INC014442107COMMON STOCK1,203,462$10,679,000thousands by filing date
AERIE PHARMACEUTICALS INC00771V108COM211,823$10,062,000thousands by filing date
SI BONE INC825704109COM205,621$3,874,000thousands by filing date
VOYAGER THERAPEUTICS INC92915B106COMMON STOCK177,804$3,403,000thousands by filing date
Arbutus Biopharma Corp03879J100Common Shares, without par value804,446$2,880,000thousands by filing date
KINIKSA PHARMACEUTICALS LTDG5269C101COM CL A63,922$1,154,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001144204-19-025824this filing2019-05-14acceptance time not in the bulk data set